Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Perkins · SciRah

Researcher profile · Semantic Scholar

J. Perkins

Share profile

J. Perkins — researcher profile on SciRah

h-index: 24
Works: 140
Citations: 1,830

Most-cited papers

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation
T. Field, J. Perkins, Y. Huang, M. Kharfan-Dabaja +9 more
2010Bone Marrow Transplantation135 citations Open access
Semantic Scholar
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.
J. Perkins, T. Field, Jongphil Kim, M. Kharfan-Dabaja +9 more
2010Biology of Blood and Marrow Transplantation111 citations Open access
Semantic Scholar
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization
J. Pidala, Jongphil Kim, M. Schell, S. J. Lee +17 more
2012Bone Marrow Transplantation102 citations Open access
Semantic Scholar
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
J. Pidala, Jongphil Kim, H. Jim, M. Kharfan-Dabaja +15 more
2012Haematologica98 citations Open access
Semantic Scholar
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
D. Hoda, J. Pidala, N. Salgado-Vila, Jongphil Kim +13 more
2010Bone Marrow Transplantation76 citations
Semantic Scholar
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study
M. Kharfan-Dabaja, M. A. Al Malki, U. Deotare, R. Raj +23 more
2017British Journal of Haematology74 citations
Semantic Scholar
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality
J. Pidala, Jongphil Kim, C. Anasetti, T. Nishihori +3 more
2011Haematologica74 citations Open access
Semantic Scholar
Pharmacists' roles in oncology pharmacy services: Results of a global survey
Lisa M. Holle, Christy S. Harris, A. Chan, Rebecca Fahrenbruch +5 more
2017Journal of Oncology Pharmacy Practice62 citations
Semantic Scholar
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
M. Kharfan-Dabaja, R. Mhaskar, T. Reljic, J. Pidala +3 more
2014Cochrane Database of Systematic Reviews57 citations Open access
Semantic Scholar
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
J. Pidala, Jongphil Kim, C. Anasetti, M. Kharfan-Dabaja +5 more
2010Journal of Hematology & Oncology55 citations Open access
Semantic Scholar
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation.
J. Perkins, Jongphil Kim, C. Anasetti, H. Fernandez +7 more
2012Biology of Blood and Marrow Transplantation54 citations Open access
Semantic Scholar
ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation
J. Pidala, M. Tomblyn, T. Nishihori, E. Ayala +12 more
2011Biology of Blood and Marrow Transplantation43 citations Open access
Semantic Scholar
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia.
S. Santarone, J. Pidala, M. Di Nicola, T. Field +10 more
2011Biology of Blood and Marrow Transplantation35 citations Open access
Semantic Scholar
Dysglycemia Following Glucocorticoid Therapy for Acute Graft-versus-Host Disease Adversely Affects Transplantation Outcomes
J. Pidala, Jongphil Kim, M. Kharfan-Dabaja, T. Nishihori +5 more
2010Biology of Blood and Marrow Transplantation33 citations Open access
Semantic Scholar
Infliximab for managing steroid-refractory acute graft-versus-host disease.
J. Pidala, Jongphil Kim, T. Field, A. McBride +6 more
2009Biology of Blood and Marrow Transplantation31 citations Open access
Semantic Scholar
Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
J. Pidala, Jongphil Kim, J. Perkins, T. Field +5 more
2010Bone Marrow Transplantation29 citations Open access
Semantic Scholar
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
M. Kharfan-Dabaja, J. Chavez, Dao-Hai Yu, Wei-Wei Zhu +14 more
2011Biology of Blood and Marrow Transplantation28 citations Open access
Semantic Scholar
Voriconazole Provides Effective Prophylaxis for Invasive Fungal Infection in Patients Receiving Glucocorticoid Therapy for Graft-Versus-Host Disease
U. Gergis, K. Markey, J. Greene, M. Kharfan-Dabaja +6 more
2009Bone Marrow Transplantation27 citations Open access
Semantic Scholar
Enhancing Student Knowledge Through a Comprehensive Oncology Simulation
Erini S. Serag-Bolos, Melissa Chudow, J. Perkins, Radha V. Patel
2018American Journal of Pharmaceutical Education25 citations Open access
Semantic Scholar
Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma
S. Parmar, Ryan Bookout, J. Shapiro, R. Tombleson +6 more
2014Bone Marrow Transplantation25 citations Open access
Semantic Scholar
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity
J. Pidala, Jongphil Kim, C. Anasetti, M. Kharfan-Dabaja +5 more
2010Bone Marrow Transplantation23 citations Open access
Semantic Scholar
TP53 and IDH2 somatic mutations are associated with inferior overall survival following allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
M. Kharfan-Dabaja, R. Komrokji, Qing Zhang, Ambuj Kumar +15 more
2017Clinical Lymphoma, Myeloma & Leukemia21 citations Open access
Semantic Scholar
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models.
V. Duong, J. Lancet, E. Alrawi, Najla Al-Ali +6 more
2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis20 citations
Semantic Scholar
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome.
T. Nishihori, J. Perkins, A. Mishra, R. Komrokji +8 more
2014Biology of Blood and Marrow Transplantation19 citations Open access
Semantic Scholar
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids
J. Pidala, M. Tomblyn, T. Nishihori, T. Field +8 more
2011Haematologica18 citations Open access
Semantic Scholar
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
J. Pidala, Jaime Román-Díaz, Jongphil Kim, T. Nishihori +9 more
2011International journal of hematology15 citations Open access
Semantic Scholar
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes
J. Perkins, T. Field, Jongphil Kim, M. Kharfan-Dabaja +10 more
2011Bone Marrow Transplantation15 citations Open access
Semantic Scholar
Phase II Study of CD4+-Guided Pentostatin Lymphodepletion and Pharmacokinetically Targeted Busulfan as Conditioning for Hematopoietic Cell Allografting
M. Kharfan-Dabaja, C. Anasetti, H. Fernandez, J. Perkins +10 more
2013Biology of Blood and Marrow Transplantation11 citations Open access
Semantic Scholar
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
M. Kharfan-Dabaja, R. Parody, J. Perkins, O. López-Godino +16 more
2017Bone Marrow Transplantation10 citations
Semantic Scholar
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
Ghada M. Kunter, J. Perkins, J. Pidala, T. Nishihori +11 more
2014Bone Marrow Transplantation10 citations
Semantic Scholar
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: Clinical and economic outcomes
J. Perkins, J. Shapiro, Ryan N. Bookout, Gary C. Yee +3 more
2012American journal of hematology/oncology10 citations Open access
Semantic Scholar
Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia
Elizabeth DiMaggio, Jun-min Zhou, R. Caddell, R. Tombleson +9 more
2020Leukemia and Lymphoma9 citations Open access
Semantic Scholar
Effectiveness of a pharmacy teaching certificate program offered to practicing pharmacists.
Jaclyn D. Cole, Melissa J. Ruble, Gwendolyn A. Wantuch, Kamila A. Dell +3 more
2019Currents in Pharmacy Teaching and Learning8 citations
Semantic Scholar
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma.
E. Ayala, J. Figueroa, J. Perkins, Jongphil Kim +6 more
2015Clinical Lymphoma, Myeloma & Leukemia8 citations
Semantic Scholar
Evaluation of a Risk-Based Algorithm for the Utilization of Plerixafor As Primary Mobilization of CD34+ Cells in Autologous Hematopoietic Cell Transplant Candidates,
J. Shapiro, J. Perkins, Ryan Bookout, R. Tombleson +4 more
20118 citations
Semantic Scholar
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience
R. Nelson, J. Shapiro, J. Perkins, Jongphil Kim +15 more
2015Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Real‐World Cardiovascular Outcomes of GLP‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
Cyrille K. Cornelio, K. Cowart, J. Perkins, Mohammed E. Alomar +4 more
2026Pharmacotherapy4 citations
Semantic Scholar
Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
R. Komrokji, N. Al Ali, E. Alrawi, E. Padron +4 more
20114 citations
Semantic Scholar
Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) in Combination With Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
J. Perkins, T. Fields, Jin Seok Kim, H. Fernandez +6 more
20114 citations Open access
Semantic Scholar
Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients.
Teresa T. Ho, J. Perkins, Rebecca M. Gonzalez, J. K. Hicks +11 more
2024Pharmacogenomics (London)3 citations
Semantic Scholar
Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates
J. Perkins, S. Goldstein, J. Dawson, Jongphil Kim +8 more
2011Clinical Cancer Research3 citations Open access
Semantic Scholar
Allogeneic hematopoietic cell transplantation for myelofibrosis: A 10‐year experience at single institution
T. Nishihori, J. Perkins, Jongphil Kim, T. Field +6 more
2010American journal of hematology/oncology3 citations Open access
Semantic Scholar
A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival
J. Perkins, M. Alsina, C. Anasetti, E. Ayala +9 more
20093 citations Open access
Semantic Scholar
Retrospective Comparison Of Secondary Mobilization Strategies In Candidates For Autologous Hematopoietic Cell Transplantion With A Focus On Resource Utilization: Plerixafor+G-CSF Versus Other Regimens
J. Perkins, Ryan Bookout, J. Sapiro, M. Alsina +10 more
20102 citations Open access
Semantic Scholar
Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation
J. Frimpong, R. Tombleson, M. Alsina, J. Shapiro +4 more
20161 citations
Semantic Scholar
TP53 and IDH2 Somatic Mutations Are Associated with Poor Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
M. Kharfan-Dabaja, R. Komrokji, Qing Zhang, D. Sallman +13 more
20151 citations
Semantic Scholar
Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) Not in First Remission
K. Sweet, J. Lancet, R. Hillgruber, M. Melody +4 more
20151 citations
Semantic Scholar
Comparison of Mycophenolate Mofetil (MMF) Versus Methotrexate (MTX) for Prevention of Acute Graft-Versus-Host Disease: Results of a Meta-Analysis
M. Kharfan-Dabaja, R. Mhaskar, J. Pidala, J. Perkins +2 more
20121 citations Open access
Semantic Scholar
Impact of a Lower Busulfan Area Under the Concentration-Time Curve (AUC) Dosing Target on Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes
A. Cruz-Chacón, J. Perkins, J. Pidala, Jongphil Kim +3 more
20121 citations Open access
Semantic Scholar
Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
J. Figueroa, J. Perkins, C. Anassetti, M. Tomblyn +9 more
20121 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Field×34
Invite
T. Field — researcher profile on SciRah
C. Anasetti×34
Invite
C. Anasetti — researcher profile on SciRah
M. Kharfan-Dabaja×29
Invite
M. Kharfan-Dabaja — researcher profile on SciRah
E. Ayala×25
Invite
E. Ayala — researcher profile on SciRah

×25

Invite

H. Fernandez — researcher profile on SciRah

Invite

L. Perez — researcher profile on SciRah

Invite

J. Pidala — researcher profile on SciRah

T. Nishihori×22

Invite

T. Nishihori — researcher profile on SciRah

Jongphil Kim×20

Invite

Jongphil Kim — researcher profile on SciRah

Invite

M. Alsina — researcher profile on SciRah

Invite

M. Tomblyn — researcher profile on SciRah

Invite

F. Locke — researcher profile on SciRah